Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I anti-BCMA CAR5 T-cell trial in Thai patients with relapsed/refractory multiple myeloma
TCTR20240527001Phase 1Not yet recruiting
- Sponsor
- Mahidol University
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in multiple myeloma (MM), sponsored by Mahidol University. Primary endpoints: Suspected adverse events, Suspected serious adverse events and 2 more. Planned start Jun 2024; status: not yet recruiting.
02
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on TCTR20240527001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240527001.